Connection

PERUMAL THIAGARAJAN to Dose-Response Relationship, Drug

This is a "connection" page, showing publications PERUMAL THIAGARAJAN has written about Dose-Response Relationship, Drug.
  1. Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway. Cancer Med. 2017 Apr; 6(4):809-818.
    View in: PubMed
    Score: 0.104
  2. Inhibition of thrombin activity by prothrombin activation fragment 1.2. J Thromb Thrombolysis. 2007 Oct; 24(2):157-62.
    View in: PubMed
    Score: 0.052
  3. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1065-70.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.